实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (5): 692-695.doi: 10.3969/j.issn.1672-5069.2019.05.020

• 肝硬化 • 上一篇    下一篇

内镜下序贯套扎和硬化剂治疗肝硬化并发食管胃底静脉曲张破裂出血患者疗效及对血流动力学的影响对比研究*

丹珠永吉, 刘芝兰, 禄艳艳, 蒋汉梅   

  1. 810000西宁市 青海省人民医院消化内科(丹珠永吉,刘芝兰,禄艳艳); 青海大学附属医院消化内科(蒋汉梅)
  • 收稿日期:2018-10-22 出版日期:2019-09-10 发布日期:2019-09-16
  • 作者简介:丹珠永吉,女,41岁,大学本科,副主任医师。主要从事消化内镜与消化道早癌诊治研究 。E-mail:shaotianyue152@163.com
  • 基金资助:
    青海省自然科学基金资助项目(编号:9673672)

Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding

Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al   

  1. Department of Gastroenterology, Provincial People's Hospital, Xining 810000, Qinghai Province,China
  • Received:2018-10-22 Online:2019-09-10 Published:2019-09-16

摘要: 目的 探讨在内镜下套扎序贯硬化剂治疗肝硬化并发食管胃底静脉曲张破裂出血(EGVB)患者的疗效及对患者血清胃泌素(GAS)、胰高血糖素(GLC)和血流动力学的影响。方法 2016年2月~2017年10月我院诊治的乙型肝炎肝硬化并发EGVB患者80例,采用随机数字表法将其分为研究组40例和对照组40例,给予对照组患者放置三腔二囊管、奥美拉唑和奥曲肽等内科常规止血治疗,研究组在此基础上待病情稳定后,采用内镜下套扎序贯硬化剂(EVLS)治疗。采用ELISA法检测血清GAS和GLC水平,使用KAI-X10四维彩色多普勒超声诊断仪检测门静脉压(PVP)、门静脉内径(PVD)、门静脉血流速度(PVV)和门静脉血流量(PVF)。随访12个月。结果 在治疗2 w内,研究组死亡3例(7.5%),对照组死亡10例(25.0%),研究组止血有效率为92.5%,显著高于对照组的75.0%(P<0.05);研究组PVP、PVD和PVF分别为(22.5±1.6) mmHg、(11.7±0.4) mm和(546.2±131.6) ml/min,显著低于对照组的(25.3±2.0) mmHg、(13.8±0.5) mm和(742.6±162.8) ml/min(P<0.05);研究组血清GAS和GLC水平分别为(72.5±10.4) ng/L和(52.4±7.8) ng/L,显著低于对照组的(95.8±14.7) ng/L和(59.6±8.9) ng/L(P<0.05);随访12个月,研究组有2例(5.4%),而对照组有8例(26.7%,x2=4.114,P=0.043)发生再出血。结论 在内镜下采用EVLS治疗乙型肝炎肝硬化并发EGVB患者疗效好,且较为安全,远期效果仍有待观察。

关键词: 肝硬化, 食管胃底静脉曲张破裂出血, 内镜下套扎序贯硬化剂栓塞, 门脉血流动力学, 治疗

Abstract: Objective To investigate the efficacy of endoscopic sequential variceal 1igation plus sclerotherapy (EVLS) in treatment of patients with hepatitis B-induced liver cirrhosis (LC) complicated by esophageal gastric varices bleeding (EGVB). Methods A retrospective analysis of 80 patients with hepatitis B-induced liver cirrhosis complicated by EGVB were recruited in our hospital between February 2016 and October 2017,and the patients were randomly divided into observation (n=40) and control group (n=40). All patients received conventional hemostasis therapy,and 40 patients in observation group received EVLS at the base of conventional supporting therapy. Serum gastrin (GAS) and glucagon (GLC) levels were detected by ELISA. The portal venous pressure (PVP),portal vein diameter (PVD),portal vein velocity (PVV) and portal vein blood flow (PVF) were detected by ultrasound. All patients were followed-up for 12 months. Results At the end of 2 weeks,three (7.5%) in observation and 10(25.0%) in the control died,and the effective hemostatic rates were 92.5% vs. 75.0% (P<0.05) in the two groups;the PVP,PVD and PVF in the observation were(22.5±1.6) mmHg,(11.7±0.4) mm and (546.2±131.6) ml/min,significantly lower than (25.3±2.0) mmHg,(13.8±0.5) mm and (742.6±162.8) ml/min (P<0.05) in the control;serum GAS and GLC levels in the observation were (72.5±10.4) ng/L and (52.4±7.8)ng/L,significantly lower tha (95.8±14.7) ng/L and (59.6±8.9) ng/L (P<0.05) in the control;at the end of 12 month follow-up,2(5.4%) patients in the observation,while 8(26.7%,x2=4.114,P=0.043) patients in the control had re-bleeding. Conclusion The application of EVLS at the base of conventional supporting therapy in the treatment of patients with liver cirrhosis with EGVB is highly efficacious and safe, which warrants further investigation.

Key words: Liver cirrhosis, Esophageal gastric varices bleeding, Endoscopic sequential variceal 1igation plus sclerotherapy, Portal hemodynamics, Therapy